Search
for

    Glossary Dasatinib

    medication used to treat certain types of leukemia

    Dasatinib is a medication primarily used to treat certain types of leukemia, a cancer of the blood cells. It works by inhibiting specific proteins that promote the growth of cancer cells, thereby slowing or stopping their proliferation. For professionals, it's known as a tyrosine kinase inhibitor and is effective against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome.

    Sort by

    Research 30 of 100

    1. Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia Journal of the American Academy of Dermatology · 2013 · 25 citations
    2. Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia JAMA Dermatology · 2013 · 9 citations
    3. Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects Current drug metabolism · 2009 · 508 citations
    4. Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Dermatology · 2015 · 32 citations
    5. Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis JAMA Dermatology · 2013 · 9 citations
    6. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers Experimental dermatology · 2022 · 7 citations
    7. A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating Strategies Pharmaceutics · 2025
    8. Targeting IGF1‐Induced Cellular Senescence to Rejuvenate Hair Follicle Aging Aging Cell · 2025
    9. Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report Case Reports in Hematology · 2025
    10. Restoration of hair follicle inductive properties by depletion of senescent cells Aging Cell · 2024
    11. Abstract 2962: Chemotherapy induced senescence drives peripheral neuropathy Cancer Research · 2024
    12. Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib Journal of clinical medicine · 2023
    13. The PDGF/PDGFR pathway as a drug target Molecular Aspects of Medicine · 2017 · 182 citations
    14. Dermatological adverse events with taxane chemotherapy European Journal of Dermatology · 2016 · 141 citations
    15. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    16. Adverse effects of common medications on male fertility Nature Reviews Urology · 2015 · 77 citations
    17. Anagen effluvium Indian Journal of Dermatology, Venereology and Leprology · 2013 · 61 citations
    18. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    19. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia Cell Death and Disease · 2016 · 38 citations
    20. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    21. Cellular senescence in tissue repair: every cloud has a silver lining The International Journal of Developmental Biology · 2018 · 33 citations
    22. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    23. A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib JAMA Dermatology · 2013 · 16 citations
    24. New small molecules in dermatology: for the autoimmunity, inflammation and beyond Inflammation Research · 2023 · 9 citations
    25. Materials, Syntheses and Biomedical Applications of Nano-Quercetin Formulations: A Comprehensive Literature Review International Journal of Nanomedicine · 2025 · 4 citations
    26. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations
    27. Causality of Aging Hallmarks Aging and Disease · 2025 · 1 citations
    28. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    29. Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review Quality in Sport · 2026
    30. Homeodynamic Rejuvenation: an adaptive framework for resetting skin aging Frontiers in Aging · 2026